Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A., Inc., Prod# (NDC): 68788-7865-05
Published October 14, 2026 · Recall initiated: September 28, 2026
Summary
FDA records drug Class II recall D-0013-2027, published October 14, 2026 and initiated September 28, 2026. Recalling firm: Preferred Pharmaceuticals, Inc.; Status: Ongoing; Reported quantity: N/A; Lot: Lot #: F1925G, Expiry: 4/30/2027; Lot #: E0925T, Expiry: 4/30/2027; Lot # D3025M, Expiry: 4/30/2027; Lot #: D0825D, Expiry: 4/30/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Content Uniformity Specifications
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Distributor
- USA Nationwide
- Lot
- Lot #: F1925G, Expiry: 4/30/2027; Lot #: E0925T, Expiry: 4/30/2027; Lot # D3025M, Expiry: 4/30/2027; Lot #: D0825D, Expiry: 4/30/2027.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAArtificial Tears Lubricant Eye Drops, Visine, Pkg Size: 15, Mfg: Geri-Care: Brooklyn, NY. NDC: 68788-7266-0November 11, 2026
- FDABiospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDCOctober 14, 2026
- FDAFosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-DoseOctober 14, 2026
- FDAArtificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 ozApril 15, 2026
- FDAOndansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged byDecember 24, 2025
- FDAClindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark PharmaceuticalsMay 7, 2025
Questions about this recall
Was Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A., Inc., Prod# (NDC): 68788-7865-05 recalled?
Yes. FDA published recall D-0013-2027 on October 14, 2026. Reported hazard: Failed Content Uniformity Specifications
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail